Trials / Withdrawn
WithdrawnNCT05710146
Tranexamic Acid (TXA) in Hip Arthroscopy
Assessing the Efficacy of Tranexamic Acid (TXA) in Hip Arthroscopy: A Randomized, Controlled Trial
- Status
- Withdrawn
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Northwestern University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The primary goal of this study will be to determine if perioperative IV Tranexamic Acid (TXA) administration will reduce intra-operative bleeding and subsequently improve visual clarity during surgery and reduce operative traction time in patients undergoing hip arthroscopy. Additionally, this study aims to determine whether IV TXA injections will reduce post-operative pain and affect hip-specific patient-reported outcomes in patients undergoing hip arthroscopy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Tranexamic acid | 1 injection of 15mg/kg of TXA in 100mL of normal saline |
| DRUG | Placebo | 1 injection of 100mL of normal saline |
Timeline
- Start date
- 2023-12-01
- Primary completion
- 2024-03-01
- Completion
- 2024-09-01
- First posted
- 2023-02-02
- Last updated
- 2023-02-02
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT05710146. Inclusion in this directory is not an endorsement.